AI In Medical Imaging Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

Global AI In Medical Imaging Market Trends and Insights

Rapid expansion of multi-vendor PACS interoperability standards in U.S. and EU

Cross-border imaging exchange rules from the EU eHealth Network and upcoming U.S. interoperability provisions allow algorithms to read scans stored on any certified PACS. Early pilots using FHIR-based federated frameworks achieved 95% data-retrieval accuracy and cut latency by 38%, enabling faster triage in acute settings while maintaining data sovereignty

Accelerating oncology screening mandates in Asia (China, Japan, South Korea)

Government-funded programs are adding millions of extra CT and endoscopy exams each year. South Korea’s national gastric-cancer initiative demonstrates favorable cost-utility ratios, and Japan now detects 70% of lung cancers at Stage I or II when AI flags incidental nodules.

Large-scale national AI diagnostics grants

Programs such as NIH Bridge2AI are funding algorithm development, workforce training, and bias-mitigation research. In the United Kingdom, NHS-AI pilots of e-Stroke have lifted mechanical-thrombectomy rates by 62% and shortened patient transfer times, translating research investment into measurable care improvements.

Growing shortage of radiologists boosting teleradiology adoption in Nordics & GCC

Rising scan volumes and limited specialist availability press health systems to outsource reads. AI-enhanced teleradiology platforms now offer automated triage, structured reporting, and quality-control dashboards, helping providers uphold turnaround-time targets without expanding headcount.

Fragmented data-governance laws are hindering cross-border AI model training

The EU AI Act classifies diagnostic algorithms as high-risk, demanding rigorous conformity assessments. Divergent consent rules across Asia further limit the use of multi-country datasets, which in turn degrade model generalizability and slow down approvals, especially for rare-disease cohorts.^{[2]European Commission, “Artificial Intelligence Act – High-Risk Medical Devices,” ec.europa.eu}

High per-scan inference costs on edge GPUs in low-volume clinics

GPU hardware enables sub-second inference but remains expensive. Benchmark tests show bone-age models jump from 1.4 to 267 images per second on GPUs, yet capital and maintenance outlays restrict adoption to larger hubs. CPU-optimized toolkits from Intel offer relief but are still rolling out.^{[1] Intel, “AI-Driven Medical Imaging Performance on Xeon and Arc Architecture,” intel.com}

*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.

Segment Analysis

By Offering: Platforms Consolidate Enterprise Workflows

The software tools and platforms segment captured 57.30% of 2025 revenue, underlining its role as the operating layer for algorithm orchestration and lifecycle management across hospital networks. Services are adding value through workflow redesign and post-deployment monitoring and are forecast to post the fastest 31.4% CAGR during 2026-2031. Vendors now bundle implementation, clinical-validation and cybersecurity support, reflecting provider preference for turnkey engagements that minimize disruption. Edge-enabled appliances remain a niche but are gaining traction for stroke and trauma hubs where every second matters. Hospitals appreciate vendor-neutral marketplaces that host dozens of cleared algorithms behind a single sign-on. GE HealthCare’s Genesis stack lets radiologists select applications à la carte and deploy updates without manual re-validation, lowering total cost of ownership and accelerating time-to-benefit GE HealthCare. Such architectures anchor the AI in medical imaging market and will shape procurement for the remainder of the decade. 

By Imaging Modality: CT Holds Lead, Ultrasound Rises Fast

CT retained 27.60% share of the AI in medical imaging market in 2025 thanks to its ubiquity in trauma, chest and neuro protocols. Algorithmic triage in stroke care is now standard in many urban stroke centers, shrinking door-to-needle times. Photon-counting CT, newly commercialized, promises sharper cardiac images, opening fertile ground for next-generation models. Ultrasound is projected to outpace all other modalities with a 31.0% CAGR through 2031. Hand-held probes paired with real-time AI guidance help emergency staff locate internal bleeding and assist midwives in fetal-growth checks. The portability of modern devices increases scan frequency, feeding ever larger datasets into training pipelines. MRI and PET continue to see algorithmic gains in noise reduction and quantitative mapping, yet their growth remains tied to scanner throughput constraints and reimbursement complexities. 

By Application: Oncology Remains Anchor, Pulmonology Accelerates

Oncology commanded 30.40% of 2025 revenue, cementing its position as the largest use-case cluster within the AI in medical imaging market. Algorithms now delineate tumors, assign TNM stages and estimate therapy response, assisting multidisciplinary boards in treatment planning. Radiomics features extracted by AI also inform early-phase drug trials, shortening discovery cycles for pharma partners. Pulmonology will expand the fastest at 33.5% CAGR during 2026-2031. COVID-19 left health systems with heightened vigilance on respiratory conditions, spurring investment in tools that detect interstitial lung disease, pulmonary embolism and chronic obstructive patterns. AI platforms that scan chest radiographs in community clinics catch abnormalities quickly and route suspicious cases for confirmatory CT, supporting earlier interventions. 

By Deployment Model: Cloud Adoption Gains Momentum

On-premise installations still represent 63.20% of current deployments, a legacy of stringent data-security policies and real-time performance needs. Yet the economics of scale now favor hosted models. Cloud-ready archives slash infrastructure refresh costs and enable cross-site reading pools, pivotal for networks coping with staff shortages. The cloud segment is slated to post a 35.4% CAGR through 2031, making it the fastest-growing deployment tier within the AI in medical imaging market. Hybrid architectures bring local caching for urgent studies and cloud elasticity for longitudinal analytics. Philips HealthSuite Imaging on Amazon Web Services illustrates how vendors blend local responsiveness with centralized governance, delivering unified worklists to radiologists irrespective of location

By End User: Hospitals Dominate, Teleradiology Providers Surge

Hospitals and clinics held 70.30% revenue share in 2025, reflecting their ownership of advanced scanners, Picture Archiving systems and specialist expertise. Survey data show almost one-half of large hospitals already use at least one imaging-AI tool in regular practice. They seek unified dashboards that highlight critical cases, automate measurements and feed structured findings into electronic health records. Teleradiology providers will record a 34.9% CAGR, the highest across end-user groups. Regional hubs redistribute workload across time zones so reports arrive before morning rounds. AI accelerates preliminary reads, allowing scarce subspecialists to focus on complex studies while maintaining rapid turnaround. Ambulatory surgery centers and academic institutes adopt AI mainly for workflow efficiency, quality assurance and algorithm-validation research.

Geography Analysis

North America led the AI in medical imaging market with 40.60% share in 2025. Robust health IT infrastructure, proactive FDA clearances and reimbursement pathways bolster adoption. Integrated Delivery Networks rapidly migrate archives to the cloud to pool radiologists and unlock predictive analytics. Canada’s fresh approval of chest and neuro AI applications signals wider regional uptake. Asia is the fastest-growing geography, projected at 32.5% CAGR to 2031. China counts dozens of homegrown cleared devices, and Japan funds nationwide lung-cancer screening that leans heavily on AI triage. South Korea’s national programs display cost-effectiveness that encourages similar rollouts. India advances TB-focused tools for low-resource clinics, highlighting the versatility of AI across income brackets. Europe balances opportunity and caution. The Medical Devices Regulation heightens compliance requirements, yet pan-EU image-exchange guidelines unlock a broader data pool that benefits algorithm robustness. The Nordics pioneer teleradiology to serve remote regions, while France embarks on long-term imaging-value partnerships that incorporate sustainability clauses and research funding. 

Regulatory Landscape

Regulation is tightening around imaging AI for Software as a Medical Device (SaMD), while also creating clearer pathways for iterative model updates. In the United States, the FDA has been formalizing how AI-enabled radiology software is classified and reviewed, including the use of Predetermined Change Control Plans (PCCPs). This approach lets manufacturers make pre-authorized modifications under defined controls, rather than treating every update as a new submission.

In June 2026, the FDA published a final order (effective June 17, 2026) that codified radiological machine learning-based quantitative imaging software with a PCCP into Class II with specific special controls. It reinforces lifecycle governance and post-market expectations for adaptive algorithms. Globally, the International Medical Device Regulators Forum (IMDRF) opened public consultation in April 2026 on a Technical Framework for Artificial Intelligence Life Cycle Management (consultation closing July 10, 2026), pointing to continued convergence on risk management, human oversight, and change management across markets.

Value Chain Analysis

The value chain starts with data generation and capture on imaging modalities (CT, MRI, X-ray, ultrasound), then moves into image management (PACS/VNA and enterprise imaging), algorithm development and validation, regulatory clearance, and deployment into clinical workflows. Imaging OEMs such as GE HealthCare, Siemens Healthineers, Philips, and Canon increasingly package AI into modality workstations and enterprise stacks, while AI-native vendors (including Aidoc, Lunit, and Qure.ai) supply condition-specific modules that need integration with existing PACS/RIS/EHR workflows. Cloud and compute layers from hyperscalers and accelerators (including NVIDIA) also matter, particularly as provider groups migrate archives and standardize multi-site reading.

Commercialization and scaling rely on orchestration and governance platforms that manage multi-vendor algorithm marketplaces, monitoring, and updates. Service partners support workflow redesign, cybersecurity, and post-deployment performance tracking. Bottlenecks persist around data liquidity and exchange, as cross-border sharing shifts from fragmented, legacy setups to cloud-enabled exchange. This is happening alongside growing integration and operational burdens when multiple algorithms are deployed across sites, under evolving regulatory expectations such as EU MDR and emerging AI-specific requirements in Europe, while U.S. processes increasingly emphasize PCCP-style lifecycle management for updates.

Market Opportunities and Future Outlook

A key opportunity lies in lifecycle-managed, continuously improving imaging AI products, supported by clearer regulatory mechanisms for controlled updates. The FDA final order effective June 17, 2026, which codifies radiological machine learning-based quantitative imaging software with a PCCP into Class II with special controls, offers a more structured route for vendors to operationalize frequent model upgrades. That framework better aligns with hospital demand for faster refresh cycles and supports vendor-neutral marketplace strategies.

There is also whitespace in multi-indication workflows and modality expansion beyond single-use tools, particularly where vendors can bundle triage, measurement, and reporting assistance into enterprise platforms. Recent FDA 510(k) clearances reflect this direction, including Philips advancing AI-enabled imaging workflows across CT and ultrasound with new clearances in 2026, and GE HealthCare adding AI-enabled auto-contouring for radiation therapy planning with a PCCP-backed product update. As cloud-first enterprise imaging consolidates, vendors that pair interoperable integration (PACS/VNA and cross-site reading) with governance features such as monitoring, audit trails, and controlled change management are positioned to support provider requirements in oncology, acute triage, and high-volume routine imaging.